#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma metastatic Severe myoclonic epilepsy of infancy B precursor type acute leukaemia Allogenic stem cell transplantation Cardiac arrest Pyruvate dehydrogenase complex deficiency Transferrin decreased Osteosarcoma Cutaneous calcification Short-bowel syndrome Endometrial adenocarcinoma Plasma cell myeloma refractory Neuroendocrine cell hyperplasia of infancy Amyloidosis Neurotrophic keratopathy More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Treatment Haemolytic uraemic syndrome Antithrombin III deficiency – Diagnostics Primary immunodeficiency syndrome – Life with Disease Ewing’s sarcoma – Life with Disease Mucopolysaccharidosis III – Treatment Alagille syndrome – Basic Information Angelman’s syndrome – Diagnostics Ocular melanoma – Trials in Disease Epidermolysis bullosa – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thiamine Nitrate Bp CITRIC ACID ANHYDROUS Caspofungin Acetate Heparin Olaptesed Pegol HALOBETASOL PROPIONATE Blinatumomab Boserolimab Gefurulimab Gallium (68Ga) Psma-R2 Abc-23B-116 HYPOCHLOROUS ACID Encaleret Sulfate Sacituzumab Govitecan L-Histidine Doxylamine Hydrogen Succinate Floxuridine Enoxaparin Sodium Poa Pratensis Lidocaine Hydrochloride More therapies…

    Learn about Your Condition

    Osteomyelitis acute Chronic coronary syndrome Emphysema Obstructive airways disorder Macular oedema Uveitis White matter lesion Osteogenesis imperfecta Chronic kidney disease Muscular dystrophy Primary hyperaldosteronism Malignant peritoneal neoplasm Thromboangiitis obliterans Neurofibromatosis Psoriatic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • Study on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Rivaroxaban
    Belgium France Germany

  • Study on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Italy Poland Spain

  • Study on the Effect of Dapagliflozin in Reducing Proteinuria in Patients with Chronic Kidney Disease After Kidney Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    France

  • Study on Retatrutide and Placebo for Kidney Function in Overweight or Obese Patients with Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Ly3437943 Sodium
    • Iohexol
    Italy Spain

  • Study on the Effect of Patiromer on Vascular Health in Patients with Chronic Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Patiromer
    Spain

  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Glargine
    Austria Czechia Germany Greece Italy Romania +2
Previous Page
1 … 8 9 10 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!